AJR Am J Roentgenol

1. HUBER AT, Obmann V
   Beyond the AJR: Prognostic Value of a Single Baseline Liver Stiffness Measurement by MR Elastography in Patients With Chronic Liver Disease.
   AJR Am J Roentgenol. 2022;219:169.
   

   >> Share

   
   
2. YOUNG S
   Editorial Comment: Echocardiography-Should It Be Routine Before Elective TIPS?
   AJR Am J Roentgenol. 2022 Mar 2. doi: 10.2214/AJR.22.27580.
   

   >> Share

   
   
3. CANNELLA R
   Editorial Comment: LI-RADS Provides High Accuracy for Liver Transplant Eligibility in High-Risk Patients.
   AJR Am J Roentgenol. 2022;219:96.
   

   >> Share

   
   
4. GEE MS
   Editorial Comment: Novel Associations Between Quantitative MRI Metrics and Clinical Risk Scores in Young Patients With Autoimmune Liver Disease.
   AJR Am J Roentgenol. 2022 Feb 2. doi: 10.2214/AJR.22.27453.
   

   >> Share

   
   
5. MCCRARY J, Trout AT, Mahalingam N, Singh R, et al
   Associations Between Quantitative MRI Metrics and Clinical Risk Scores in Children and Young Adults With Autoimmune Liver Disease.
   AJR Am J Roentgenol. 2022 Jan 26. doi: 10.2214/AJR.21.27204.
   

   >> Share

   
   

   
   Am J Pathol

6. ROY N, Alencastro F, Roseman BA, Wilson SR, et al
   Dysregulation of Lipid and Glucose Homeostasis in Hepatocyte-Specific SLC25A34 Knockout Mice.
   Am J Pathol. 2022 Jun 16. pii: S0002-9440(22)00172.
   

   >> Share

   
   

   
   Biochem Biophys Res Commun

7. SAKURAI M, Weber P, Wolff G, Wieder A, et al
   TSC22D4 promotes TGFbeta1-induced activation of hepatic stellate cells.
   Biochem Biophys Res Commun. 2022;618:46-53.
   

   >> Share

   
   
8. WU W, Lu P, Huang Y, Zhu Z, et al
   Emodin regulates the autophagy via the miR-371a-5p/PTEN axis to inhibit hepatic malignancy.
   Biochem Biophys Res Commun. 2022;619:1-8.
   

   >> Share

   
   
9. JUNG SY, Yun HH, Lim JH, Lee DH, et al
   Hepatocyte-specific deletion of Bis causes senescence in the liver without deteriorating hepatic function.
   Biochem Biophys Res Commun. 2022;619:42-48.
   

   >> Share

   
   
10. LI S, Wang Y, Dun W, Han W, et al
    Phosphoproteomic analysis of FAC overload-triggered human hepatic cells reveals G2/M phase arrest.
    Biochem Biophys Res Commun. 2022;619:62-67.
    

    >> Share

    
    
11. PEI Y, Balogun O, Otieno D, Parks JS, et al
    The effects of brewers' spent grain on high-fat diet-induced fatty liver.
    Biochem Biophys Res Commun. 2022;616:49-55.
    

    >> Share

    
    

    
    BMC Cancer

12. YAMAGUCHI F, Hirata Y, Akram H, Kamitori K, et al
    Editorial Expression of Concern: FOXO/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801.
    BMC Cancer. 2022;22:665.
    

    >> Share

    
    
13. GUADAGNI S, Masedu F, Fiorentini G, Sarti D, et al
    Circulating tumour cell gene expression and chemosensitivity analyses: predictive accuracy for response to multidisciplinary treatment of patients with unresectable refractory recurrent rectal cancer or unresectable refractory colorectal cancer liver
    BMC Cancer. 2022;22:660.
    

    >> Share

    
    
14. JIANG AN, Wang B, Wang S, Zhao K, et al
    The study of direct and indirect effects of radiofrequency ablation on tumor microenvironment in liver tumor animal model.
    BMC Cancer. 2022;22:663.
    

    >> Share

    
    
15. QIN B, Zeng Z, Xu J, Shangwen J, et al
    Emodin inhibits invasion and migration of hepatocellular carcinoma cells via regulating autophagy-mediated degradation of snail and beta-catenin.
    BMC Cancer. 2022;22:671.
    

    >> Share

    
    
16. LI N, Wan X, Zhang H, Zhang Z, et al
    Tumor and peritumor radiomics analysis based on contrast-enhanced CT for predicting early and late recurrence of hepatocellular carcinoma after liver resection.
    BMC Cancer. 2022;22:664.
    

    >> Share

    
    
17. HUANG WJ, Wang GY, Liu ZY, Zhang ML, et al
    Preoperative PDW levels predict pulmonary metastasis in patients with hepatocellular carcinoma.
    BMC Cancer. 2022;22:683.
    

    >> Share

    
    

    
    BMC Gastroenterol

18. HAN D, Zhang H, Liu S, Zhuang L, et al
    Association between the LRP5 rs556442 gene polymorphism and the risks of NAFLD and CHD in a Chinese Han population.
    BMC Gastroenterol. 2022;22:305.
    

    >> Share

    
    

    
    Br J Surg

19. SHEN Q, Li T, Zhou J
    Comment on: Early postoperative arterial lactate concentrations to stratify risk of post-hepatectomy liver failure.
    Br J Surg. 2022;109:e85.
    

    >> Share

    
    

    
    Eur Radiol

20. CHOI SJ, Choi SH, Lee DY, Lee JS, et al
    Diagnostic value of [(68) Ga]Ga-DOTA-labeled-somatostatin analogue PET/MRI for detecting liver metastasis in patients with neuroendocrine tumors: a systematic review and meta-analysis.
    Eur Radiol. 2022;32:4628-4637.
    

    >> Share

    
    
21. DIMOV IP, Tous C, Li N, Barat M, et al
    Assessment of hepatic arterial hemodynamics with 4D flow MRI: in vitro analysis of motion and spatial resolution related error and in vivo feasibility study in 20 volunteers.
    Eur Radiol. 2022 Jun 22. pii: 10.1007/s00330-022-08890.
    

    >> Share

    
    
22. KENNEDY P, Stocker D, Carbonell G, Said D, et al
    MR elastography outperforms shear wave elastography for the diagnosis of clinically significant portal hypertension.
    Eur Radiol. 2022 Jun 21. pii: 10.1007/s00330-022-08935.
    

    >> Share

    
    
23. HWANG JA, Jeong WK, Kang HJ, Lee ES, et al
    Perfluorobutane-enhanced ultrasonography with a Kupffer phase: improved diagnostic sensitivity for hepatocellular carcinoma.
    Eur Radiol. 2022 Jun 16. pii: 10.1007/s00330-022-08900.
    

    >> Share

    
    
24. JIAO CY, Zhang H, Ji GW, Xu Q, et al
    CT-based clinico-radiological nomograms for prognosis prediction in patients with intrahepatic mass-forming cholangiocarcinoma: a multi-institutional study.
    Eur Radiol. 2022 Jun 16. pii: 10.1007/s00330-022-08914.
    

    >> Share

    
    

    
    Gastroenterology

25. YING X, Rosenblatt R, Fortune BE
    Trends in Industry Payments to Gastroenterologists and Hepatologists in the United States from 2014 to 2020.
    Gastroenterology. 2022 Jun 14. pii: S0016-5085(22)00647.
    

    >> Share

    
    

    
    Gut

26. MITHIEUX G
    Transcription factor p63, a member of the p53 family of tumour suppressors, regulates hepatic glucose metabolism.
    Gut. 2022 Jun 15. pii: gutjnl-2022-327790. doi: 10.1136/gutjnl-2022-327790.
    

    >> Share

    
    
27. AWONIYI M, Wang J, Ngo B, Meadows V, et al
    Protective and aggressive bacterial subsets and metabolites modify hepatobiliary inflammation and fibrosis in a murine model of PSC.
    Gut. 2022 Jun 15. pii: gutjnl-2021-326500. doi: 10.1136/gutjnl-2021-326500.
    

    >> Share

    
    
28. BEA S, Jeong HE, Park S, Yu OHY, et al
    Hepatic events associated with sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes: a nationwide cohort study.
    Gut. 2022 Jun 20. pii: gutjnl-2022-327504. doi: 10.1136/gutjnl-2022-327504.
    

    >> Share

    
    

    
    Hepatology

29. JOHN BV, Doshi A, Ferreira RD, Taddei TH, et al
    Comparison of Infection-induced and Vaccine-induced Immunity Against Coronavirus 2019 in Patients with Cirrhosis.
    Hepatology. 2022 Jun 16. doi: 10.1002/hep.32619.
    

    >> Share

    
    
30. YUAN T, Zhou T, Qian M, Du J, et al
    SDHA/B reduction promotes hepatocellular carcinoma by facilitating the deNEDDylation of cullin1 and stabilizing YAP/TAZ.
    Hepatology. 2022 Jun 17. doi: 10.1002/hep.32621.
    

    >> Share

    
    
31. POVERO D, Ahn JC, Arnold J, Udompap P, et al
    Hepatology Highlights.
    Hepatology. 2022;76:1-2.
    

    >> Share

    
    
32. ZHAO K, Guo F, Wang J, Zhong Y, et al
    Limited disassembly of cytoplasmic hepatitis B virus nucleocapsids restricts viral infection in murine hepatic cells.
    Hepatology. 2022 Jun 19. doi: 10.1002/hep.32622.
    

    >> Share

    
    
33. DEVARAJ E, Perumal E, Subramaniyan R, Mustapha N, et al
    Liver fibrosis: Extracellular vesicles mediated intercellular communication in perisinusoidal space.
    Hepatology. 2022;76:275-285.
    

    >> Share

    
    
34. STINE JG, Schreibman IR, Faust AJ, Dahmus J, et al
    NASHFit: A randomized controlled trial of an exercise training program to reduce clotting risk in patients with NASH.
    Hepatology. 2022;76:172-185.
    

    >> Share

    
    
35. KAWAMURA N, Imajo K, Kalutkiewicz KJ, Nagai K, et al
    Influence of liver stiffness heterogeneity on staging fibrosis in patients with nonalcoholic fatty liver disease.
    Hepatology. 2022;76:186-195.
    

    >> Share

    
    
36. LEWIS JH
    Digitizing DILI: Who can? RUCAM? RECAM?
    Hepatology. 2022;76:3-5.
    

    >> Share

    
    
37. SERPER M, Parikh ND, Thiele G, Ovchinsky N, et al
    Patient-reported outcomes in HCC: A scoping review by the Practice Metrics Committee of the American Association for the Study of Liver Diseases.
    Hepatology. 2022;76:251-274.
    

    >> Share

    
    
38. HAYASHI PH, Lucena MI, Fontana RJ, Bjornsson ES, et al
    A revised electronic version of RUCAM for the diagnosis of DILI.
    Hepatology. 2022;76:18-31.
    

    >> Share

    
    
39. PISCAGLIA F
    Microwave ablation in skilled hands. A treatment opportunity gaining room in the field of single HCC 3-5 cm.
    Hepatology. 2022;76:6-8.
    

    >> Share

    
    
40. KAPPUS MR, Patel YA, Duarte-Rojo A
    Improving the fitness of the NASH clinical trial: Standardizing the standard-of-care intervention.
    Hepatology. 2022;76:12-14.
    

    >> Share

    
    
41. TAO X, Zhao Y, Chen L, Zeng M, et al
    Letter to the editor: Prediction of biochemical nonresolution in patients with chronic drug-induced liver injury: A large multicenter study.
    Hepatology. 2022;76:E13-E14.
    

    >> Share

    
    
42. KIVLIGHN S, Schuur E, Gish RG, Cryer D, et al
    Letter to the editor: Beneath the surface of the pandemic: Persons with alcohol-associated liver disease need our attention.
    Hepatology. 2022;76:E7-E8.
    

    >> Share

    
    
43. RASCHI E, Caraceni P
    Letter to the editor: RECAM for the diagnosis of DILI-Is it time to incorporate additional pharmacological criteria?
    Hepatology. 2022;76:E25-E26.
    

    >> Share

    
    
44. DANAN G, Teschke R
    Letter to the editor: Electronic RUCAM: Major pitfalls call for caution and proper validation.
    Hepatology. 2022;76:E27.
    

    >> Share

    
    
45. RYDELL GE, Ringlander J, Larsson SB, Hellstrand K, et al
    Letter to the editor: Alu-PCR design may have compromised detection of integrated core HBV DNA.
    Hepatology. 2022;76:E23.
    

    >> Share

    
    

    
    Int J Cancer

46. NIGER M, Nichetti F, Casadei-Gardini A, Rizzato MD, et al
    Platinum sensitivity in patients with IDH1/2 mutated versus wild-type intrahepatic cholangiocarcinoma: a propensity score-based study.
    Int J Cancer. 2022 Jun 20. doi: 10.1002/ijc.34182.
    

    >> Share

    
    

    
    J Gastroenterol Hepatol

47. WONG YJ, Li J, Liu C, Chen Z, et al
    CHESS-ALARM score to stratify decompensation risk in compensated advanced chronic liver disease patients: An international multicenter study.
    J Gastroenterol Hepatol. 2022;37:1043-1051.
    

    >> Share

    
    
48. LIU H, Yang XL, Dong ZR, Chen ZQ, et al
    Clinical Benefits of Direct-acting Antivirals Therapy in Hepatitis C Virus Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
    J Gastroenterol Hepatol. 2022 Jun 20. doi: 10.1111/jgh.15915.
    

    >> Share

    
    

    
    J Hepatol

49. JOHANSEN S, Thiele M, Juel HB, Hansen T, et al
    External validation of a genetic risk score that predicts development of alcohol-related cirrhosis.
    J Hepatol. 2022 Jun 13. pii: S0168-8278(22)00365.
    

    >> Share

    
    
50. SALEM R, Tselikas L, De Baere T
    Interventional treatment of hepatocellular carcinoma.
    J Hepatol. 2022 Jun 12. pii: S0168-8278(22)00229.
    

    >> Share

    
    
51. LURZ E, Lenz D, Bufler P, Fichtner A, et al
    Letter to the editor - A peditatric hepatologists' perspective.
    J Hepatol. 2022 Jun 14. pii: S0168-8278(22)00363.
    

    >> Share

    
    
52. BRESCIANI N, Demagny H, Lemos V, Pontanari F, et al
    SLC25A47 is a novel determinant of hepatic mitochondrial function implicated in liver fibrosis.
    J Hepatol. 2022 Jun 14. pii: S0168-8278(22)00364.
    

    >> Share

    
    
53. SCHLEGEL A, Porte RJ, Dutkowski P
    Corrigendum to 'Protective mechanisms and current clinical evidence of hypothermic oxygenated machine perfusion (HOPE) in preventing post-transplant cholangiopathy' [J Hepatol 76 (2022) 1330-1347].
    J Hepatol. 2022 Jun 16. pii: S0168-8278(22)00353.
    

    >> Share

    
    
54. 
    EASL Clinical Practice Guidelines on the management of hepatic encephalopathy.
    J Hepatol. 2022 Jun 7. pii: S0168-8278(22)00346.
    

    >> Share

    
    
55. BEAUFRERE A, Vilgrain V, Paradis V
    Reply to chao Li et al., Zi-Xiang Chen et al. and Ke-Chun Wang et al.: "Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies".
    J Hepatol. 2022 Jun 19. pii: S0168-8278(22)00374.
    

    >> Share

    
    
56. JEPSEN P, Reeves H
    Signed, SEALed, detected I'm your patient with advanced fibrosis or cirrhosis!
    J Hepatol. 2022 Jun 20. pii: S0168-8278(22)00369.
    

    >> Share

    
    
57. ALVISI G, Termanini A, Soldani C, Portale F, et al
    Multimodal single-cell profiling of intrahepatic cholangiocarcinoma defines hyperactivated Tregs as a potential therapeutic target.
    J Hepatol. 2022 Jun 20. pii: S0168-8278(22)00370.
    

    >> Share

    
    
58. MENDEZ-SANCHEZ N, Maris-Gil S, Alonso-Rivera CG
    Latin American Association of Pediatrics (ALAPE) endorses the MAFLD definition of fatty liver disease.
    J Hepatol. 2022;77:249.
    

    >> Share

    
    
59. CHEN YS, Hung YM, Wei JC
    Comment on "Exposure to air pollution is associated with an increased risk of metabolic dysfunction-associated fatty liver disease".
    J Hepatol. 2022;77:259-260.
    

    >> Share

    
    
60. MARTI-AGUADO D, Clemente-Sanchez A, Bataller R
    Cigarette smoking and liver diseases.
    J Hepatol. 2022;77:191-205.
    

    >> Share

    
    
61. YU M, Chen Z, Zhou Q, Zhang B, et al
    PARG inhibition limits HCC progression and potentiates the efficacy of immune checkpoint therapy.
    J Hepatol. 2022;77:140-151.
    

    >> Share

    
    
62. GUO B, Zhou J, Zhao X
    Reply to: "Comment on "Exposure to air pollution is associated with an increased risk of metabolic dysfunction-associated fatty liver disease"".
    J Hepatol. 2022;77:260-262.
    

    >> Share

    
    
63. BARCENA-VARELA M
    Revealing anti-PD-1 resistance mechanisms in HCC: A path towards novel combination immunotherapies.
    J Hepatol. 2022;77:9-11.
    

    >> Share

    
    

    
    Oncogene

64. WANG Y, Zhang Y, Mi J, Jiang C, et al
    ANKFN1 plays both protumorigenic and metastatic roles in hepatocellular carcinoma.
    Oncogene. 2022 Jun 21. pii: 10.1038/s41388-022-02380.
    

    >> Share

    
    

    
    PLoS One

65. KOGISO T, Sagawa T, Taniai M, Shimada E, et al
    Risk factors for Fontan-associated hepatocellular carcinoma.
    PLoS One. 2022;17:e0270230.
    

    >> Share

    
    

    
    Radiology

66. JANG JK, Lee ES, Seo JW, Kim YR, et al
    Two-dimensional Shear-Wave Elastography and US Attenuation Imaging for Nonalcoholic Steatohepatitis Diagnosis: A Cross-sectional, Multicenter Study.
    Radiology. 2022 Jun 21:220220. doi: 10.1148/radiol.220220.
    

    >> Share

    
    
67. JUNG J, Han A, Madamba E, Bettencourt R, et al
    Direct Comparison of Quantitative US versus Controlled Attenuation Parameter for Liver Fat Assessment Using MRI Proton Density Fat Fraction as the Reference Standard in Patients Suspected of Having NAFLD.
    Radiology. 2022 Mar 29:211131. doi: 10.1148/radiol.211131.
    

    >> Share

    
    

    
    Semin Liver Dis

68. GRINSPAN LT, Villanueva A
    Biomarker Development Using Liquid Biopsy in Hepatocellular Carcinoma.
    Semin Liver Dis. 2022;42:188-201.
    

    >> Share

    
    
69. CHEW N, Ng CH, Truong E, Noureddin M, et al
    Non-Alcoholic Steatohepatitis Drug Development Pipeline: An Update.
    Semin Liver Dis. 2022 Jun 16. doi: 10.1055/a-1877-9656.
    

    >> Share

    
    

    
    Transplant Proc

70. ROMERES SGB, Trevizoli NC, Oliveira CAM, Obeid EJ, et al
    Progressive Familial Intrahepatic Cholestasis Type 2 and Recurrence After Liver Transplantation: A Case Report.
    Transplant Proc. 2022 Jun 16. pii: S0041-1345(22)00271.
    

    >> Share

    
    
71. DALA RIVA DF, Nacif LS, Fernandes MR, Silva NA, et al
    Relationship of Anatomic Variations and Arterial Reconstruction of the Hepatic Artery: Prevalence and Effect on Orthotopic Liver Transplantation.
    Transplant Proc. 2022 Jun 15. pii: S0041-1345(22)00270.
    

    >> Share

    
    

    
    Transplantation

72. PERKONS NR, Metz DC, Siegelman ES, Yang Z, et al
    Where LI-RADS Falls Short: Two Cases of Image-diagnosed HCC, Found to Be NET on Explant.
    Transplantation. 2022;106:e350-e351.
    

    >> Share

    
    
73. LEE EJ, Sood V, Raghu V, Squires J, et al
    Liver Transplantation From a Heterozygous Living-related Donor Into an Alpha-1 Antitrypsin Deficient Pediatric Recipient.
    Transplantation. 2021;105.
    

    >> Share

    
    
74. BLACK K, Ziogas IA, Thurm C, Hall M, et al
    Pediatric Liver Transplant Outcomes in Alagille Syndrome: A Linked Database Analysis.
    Transplantation. 2021;105.
    

    >> Share

    
    
75. ANTALA S, Godown J, Neighbors K, Thurm C, et al
    Multi-center Study of Peri-transplant Outcomes for Acute Liver Failure in Neonates Compared to Older Infants.
    Transplantation. 2021;105.
    

    >> Share

    
    
76. TROTTER J
    Commentary on Rising Trend in Waitlisting for Alcoholic Hepatitis With More Favorable Outcomes Than Other High Model for End-stage Liver Disease in the Current Era.
    Transplantation. 2022 Mar 24. pii: 00007890-900000000-95040.
    

    >> Share

    
    
77. IVANICS T, Wallace D, Abreu P, Claasen MP, et al
    Survival After Liver Transplantation: An International Comparison Between the United States and the United Kingdom in the Years 2008-2016.
    Transplantation. 2021 Nov 9. pii: 00007890-900000000-95135.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share